H. Trent Spencer is an Associate Professor in the Department
of Pediatrics at the Emory University School of Medicine. He additionally is
the Director of the Gene and Cell Therapy Lab in the Aflac Center at Children’s
Healthcare of Atlanta. His research targets the development of gene therapy
treatments for hemophilia A and novel immunotherapy treatments for cancer that
involve genetically engineering immunocompetent cells in order to execute the
combined use of chemotherapy and cell-based cancer treatments. More broadly, he
takes interest in the development of gene therapy treatments for childhood
cancer and inherited diseases.
https://winshipcancer.emory.edu/bios/faculty/spencer-h-trent.html